Article Abstract
Questions about the efficacy of antidepressantdrugs in depression have beenraised as a result of 2 recent reports.Turner et al. reviewed industry-sponsoredclinical trials (randomized controlled trials;RCTs) submitted to the FDA and foundthat positive RCTs were more likely to besubsequently published than negative trials.The authors suggested that publisheddata overestimate the effectiveness of antidepressants.
From the Editors
New Series
The JCP Podcast
Insightful, evidence-based conversations on the latest in psychiatric care — from the editors of JCP.
Download Premium PDF
Enjoy this premium PDF as part of your membership benefits!
